In a conversation with Pharmaceutical Executive, Morten Graugaard, CEO, Orbis Medicines, discussed FDA’s approval of Icotyde ...

Veterinary Dermatology Market OverviewThe global veterinary dermatology market is projected to expand at an approximate compound annual growth rate of around nine percent over the coming five years, ...

Daily oral PrEP (generic Truvada; Descovy) is effective but adherence-sensitive, and seroconversions in trials correlate with ...

If triptans aren't alleviating your migraine attacks, learn what might be going wrong, from poor timing and low dosages to ...

The firm will deliver SGT-212 to patients' brains and intravenously to try to restore frataxin levels and diminish ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

The Blood-Brain Barrier (BBB) is a highly selective interface that protects the brain by regulating the entry of nutrients, signaling molecules, and ...

Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide, posing a major challenge to health systems. There are a variety of ...

The unit-dose amlodipine powder for oral solution provides a stable, preservative-free alternative for patients who struggle with traditional tablet formulations.

Researchers at the University of Pittsburgh gave transplant recipients certain immune cells from their organ donors. It ...

The non-small cell lung cancer clinical trial analysis report delivers important insights into ongoing research of 120+ ...

U.S. Ulcerative Colitis Market is projected to grow from USD 3.22 Billion in 2025 to USD 4.94 Billion by 2035 Increasing Cases of Ulcerative Colitis in the U.S.Austin, April 16, 2026 (GLOBE NEWSWIRE) ...